These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 18421493

  • 1. Serum levels of TRAP5b, a new bone resorption marker unaffected by renal dysfunction, as a useful marker of cortical bone loss in hemodialysis patients.
    Shidara K, Inaba M, Okuno S, Yamada S, Kumeda Y, Imanishi Y, Yamakawa T, Ishimura E, Nishizawa Y.
    Calcif Tissue Int; 2008 Apr; 82(4):278-87. PubMed ID: 18421493
    [Abstract] [Full Text] [Related]

  • 2. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y.
    Osteoporos Int; 2005 May; 16(5):501-9. PubMed ID: 15309383
    [Abstract] [Full Text] [Related]

  • 3. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients.
    Maeno Y, Inaba M, Okuno S, Yamakawa T, Ishimura E, Nishizawa Y.
    Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890
    [Abstract] [Full Text] [Related]

  • 4. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
    Inaba M, Okuno S, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa Y.
    Osteoporos Int; 2005 May; 16(5):517-25. PubMed ID: 15322741
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of bone resorption markers in hemodialysis patients.
    Hamano T, Tomida K, Mikami S, Matsui I, Fujii N, Imai E, Rakugi H, Isaka Y.
    Bone; 2009 Jul; 45 Suppl 1():S19-25. PubMed ID: 19332165
    [Abstract] [Full Text] [Related]

  • 6. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y.
    Am J Kidney Dis; 2002 Oct; 40(4):802-9. PubMed ID: 12324916
    [Abstract] [Full Text] [Related]

  • 7. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.
    Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265
    [Abstract] [Full Text] [Related]

  • 8. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Jul 22; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

  • 9. Serum cross-linked N-terminal telopeptide of type I collagen for evaluation of renal osteodystrophy in hemodialysis patients.
    Nakashima A, Yorioka N, Mizutani T, Yamagata Z, Ueno T, Takasugi N.
    Nephron Clin Pract; 2005 Jul 22; 99(3):c78-85. PubMed ID: 15665550
    [Abstract] [Full Text] [Related]

  • 10. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.
    Clin Endocrinol (Oxf); 2008 Aug 22; 69(2):189-96. PubMed ID: 18221403
    [Abstract] [Full Text] [Related]

  • 11. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
    Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.
    J Clin Endocrinol Metab; 2014 Nov 22; 99(11):4315-20. PubMed ID: 25093620
    [Abstract] [Full Text] [Related]

  • 12. [Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].
    Nowak Z, Konieczna M, Wańkowicz Z.
    Pol Merkur Lekarski; 2004 Aug 22; 17(98):138-41. PubMed ID: 15603322
    [Abstract] [Full Text] [Related]

  • 13. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Kitazono T.
    Clin Endocrinol (Oxf); 2013 Jun 22; 78(6):844-51. PubMed ID: 23078546
    [Abstract] [Full Text] [Related]

  • 14. Serum adiponectin and bone mineral density in male hemodialysis patients.
    Okuno S, Ishimura E, Norimine K, Tsuboniwa N, Kagitani S, Yamakawa K, Yamakawa T, Sato KK, Hayashi T, Shoji S, Nishizawa Y, Inaba M.
    Osteoporos Int; 2012 Jul 22; 23(7):2027-35. PubMed ID: 21927917
    [Abstract] [Full Text] [Related]

  • 15. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.
    Clin Biochem; 2014 Sep 22; 47(13-14):1316-9. PubMed ID: 24956265
    [Abstract] [Full Text] [Related]

  • 16. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
    Tsuchida T, Ishimura E, Miki T, Matsumoto N, Naka H, Jono S, Inaba M, Nishizawa Y.
    Osteoporos Int; 2005 Feb 22; 16(2):172-9. PubMed ID: 15164161
    [Abstract] [Full Text] [Related]

  • 17. Serum N-terminal midfragment vs. intact osteocalcin immunoradiometric assay as markers for bone turnover and bone loss in hemodialysis patients.
    Nagasue K, Inaba M, Okuno S, Kitatani K, Imanishi Y, Ishimura E, Miki T, Kim M, Nishizawa Y.
    Biomed Pharmacother; 2003 Mar 22; 57(2):98-104. PubMed ID: 12842495
    [Abstract] [Full Text] [Related]

  • 18. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A.
    J Nephrol; 2004 Mar 22; 17(1):87-94. PubMed ID: 15151263
    [Abstract] [Full Text] [Related]

  • 19. The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.
    Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, Hirahara F, Gorai I.
    J Bone Miner Res; 2000 Aug 22; 15(8):1537-44. PubMed ID: 10934652
    [Abstract] [Full Text] [Related]

  • 20. The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation.
    Rosen CJ, Chesnut CH, Mallinak NJ.
    J Clin Endocrinol Metab; 1997 Jun 22; 82(6):1904-10. PubMed ID: 9177404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.